610 related articles for article (PubMed ID: 23513028)
1. Intravenous antibiotics reduce the presence of Aspergillus in adult cystic fibrosis sputum.
Baxter CG; Rautemaa R; Jones AM; Webb AK; Bull M; Mahenthiralingam E; Denning DW
Thorax; 2013 Jul; 68(7):652-7. PubMed ID: 23513028
[TBL] [Abstract][Full Text] [Related]
2. Novel immunologic classification of aspergillosis in adult cystic fibrosis.
Baxter CG; Dunn G; Jones AM; Webb K; Gore R; Richardson MD; Denning DW
J Allergy Clin Immunol; 2013 Sep; 132(3):560-566.e10. PubMed ID: 23726262
[TBL] [Abstract][Full Text] [Related]
3. Aspergillus Bronchitis in Patients with Cystic Fibrosis.
Brandt C; Roehmel J; Rickerts V; Melichar V; Niemann N; Schwarz C
Mycopathologia; 2018 Feb; 183(1):61-69. PubMed ID: 28819878
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Aspergillus sensitization or persistent carriage as a factor in lung function impairment in cystic fibrosis patients.
Fillaux J; Brémont F; Murris M; Cassaing S; Rittié JL; Tétu L; Segonds C; Abbal M; Bieth E; Berry A; Pipy B; Magnaval JF
Scand J Infect Dis; 2012 Nov; 44(11):842-7. PubMed ID: 22831545
[TBL] [Abstract][Full Text] [Related]
5. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
Walicka-Serzysko K; Sands D
Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of changes in Pseudomonas aeruginosa load during treatment of a pulmonary exacerbation in cystic fibrosis.
Reid DW; Latham R; Lamont IL; Camara M; Roddam LF
J Cyst Fibros; 2013 Dec; 12(6):688-99. PubMed ID: 23706827
[TBL] [Abstract][Full Text] [Related]
7. Improved lung function and body mass index associated with long-term use of Macrolide antibiotics.
Pirzada OM; McGaw J; Taylor CJ; Everard ML
J Cyst Fibros; 2003 Jun; 2(2):69-71. PubMed ID: 15463852
[TBL] [Abstract][Full Text] [Related]
8. Aspergillus fumigatus colonization in cystic fibrosis: implications for lung function?
de Vrankrijker AM; van der Ent CK; van Berkhout FT; Stellato RK; Willems RJ; Bonten MJ; Wolfs TF
Clin Microbiol Infect; 2011 Sep; 17(9):1381-6. PubMed ID: 21087348
[TBL] [Abstract][Full Text] [Related]
9. Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis.
Reece E; Segurado R; Jackson A; McClean S; Renwick J; Greally P
BMC Pulm Med; 2017 Apr; 17(1):70. PubMed ID: 28431569
[TBL] [Abstract][Full Text] [Related]
10. Serum antibodies to Aspergillus fumigatus catalase in patients with cystic fibrosis.
Schønheyder H; Jensen T; Laessøe IH; Høiby N; Koch C
Eur J Clin Microbiol Infect Dis; 1988 Feb; 7(1):40-4. PubMed ID: 3132374
[TBL] [Abstract][Full Text] [Related]
11. Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study.
Hansen CR; Pressler T; Koch C; Høiby N
J Cyst Fibros; 2005 Mar; 4(1):35-40. PubMed ID: 15752679
[TBL] [Abstract][Full Text] [Related]
12. Aspergillus/allergic bronchopulmonary aspergillosis in an Irish cystic fibrosis population: a diagnostically challenging entity.
Chotirmall SH; Branagan P; Gunaratnam C; McElvaney NG
Respir Care; 2008 Aug; 53(8):1035-41. PubMed ID: 18655741
[TBL] [Abstract][Full Text] [Related]
13. Serum (1→3)-β-D-glucan and galactomannan levels in patients with cystic fibrosis: a retrospective cohort study.
Träger J; Melichar VO; Meyer R; Rauh M; Bogdan C; Held J
BMC Pulm Med; 2018 Mar; 18(1):52. PubMed ID: 29587700
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of glucan and galactomannan tests with real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model].
Aydoğan S; Kuştimur S; Kalkancı A
Mikrobiyol Bul; 2010 Jul; 44(3):441-52. PubMed ID: 21063994
[TBL] [Abstract][Full Text] [Related]
15. Fungal infections and treatment in cystic fibrosis.
Middleton PG; Chen SC; Meyer W
Curr Opin Pulm Med; 2013 Nov; 19(6):670-5. PubMed ID: 24060984
[TBL] [Abstract][Full Text] [Related]
16. Homogenisation of cystic fibrosis sputum by sonication--an essential step for Aspergillus PCR.
Baxter CG; Jones AM; Webb K; Denning DW
J Microbiol Methods; 2011 Apr; 85(1):75-81. PubMed ID: 21277342
[TBL] [Abstract][Full Text] [Related]
17. IgE-mediated immune responses and airway detection of Aspergillus and Candida in adult cystic fibrosis.
Baxter CG; Moore CB; Jones AM; Webb AK; Denning DW
Chest; 2013 May; 143(5):1351-1357. PubMed ID: 23139075
[TBL] [Abstract][Full Text] [Related]
18. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden.
Knudsen PK; Olesen HV; Høiby N; Johannesson M; Karpati F; Laerum BN; Meyer P; Pressler T; Lindblad A;
J Cyst Fibros; 2009 Mar; 8(2):135-42. PubMed ID: 19157995
[TBL] [Abstract][Full Text] [Related]
19. Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance.
De Baets F; Schelstraete P; Van Daele S; Haerynck F; Vaneechoutte M
J Cyst Fibros; 2007 Jan; 6(1):75-8. PubMed ID: 16793350
[TBL] [Abstract][Full Text] [Related]
20. The basophil surface marker CD203c identifies Aspergillus species sensitization in patients with cystic fibrosis.
Mirković B; Lavelle GM; Azim AA; Helma K; Gargoum FS; Molloy K; Gernez Y; Dunne K; Renwick J; Murphy P; Moss RB; Greene CM; Gunaratnam C; Chotirmall SH; McElvaney NG
J Allergy Clin Immunol; 2016 Feb; 137(2):436-443.e9. PubMed ID: 26388311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
